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ABSTRACT: Sleep duration and quality have been associated with poor physical function, but both the 
temporality of the association and the independence of sleep duration and quality are unclear. We examined the 
prospective association of sleep duration and quality with physical function impairment and disability in older 
adults. Data were taken from participants in the Seniors-ENRICA (2012-2015, n= 1,773) and in the ELSA cohort 
(waves 4 and 6, n=4,885) aged ≥60 years. Sleep duration and quality were self-reported. Physical function 
impairment and disability was obtained either from self-reports (ENRICA and ELSA) or from performance 
assessment (ENRICA). Logistic regression models were adjusted for potential confounders. After a follow-up of 
2.0-2.8 years, no association was found between changes in sleep duration and physical function impairment or 
disability. However, in both studies, poor general sleep quality was linked to higher risk of impaired agility [OR: 
1.93 (95% CI: 1.30-2.86) in Seniors-ENRICA and 1.65 (1.24-2.18) in ELSA study] and mobility [1.46 (0.98-2.17) 
in Seniors-ENRICA and 1.59 (1.18-2.15) in ELSA study]. Poor general sleep quality was also associated with 
decreased physical component summary (PCS) [1.39 (1.05-1.83)], disability in instrumental activities of daily 
living [1.59 (0.97-2.59)] and in basic activities of daily living [1.73 (1.14-2.64)] in Seniors-ENRICA. In addition, 
compared to those with no sleep complaints, participants with 2 or more sleep complaints had greater risk of 
impaired agility, impaired mobility, decreased PCS and impaired lower extremity function in both cohorts. Poor 
sleep quality was associated with higher risk of physical impairment and disability in older adults from Spain 
and from England. 
Key words: physical function, sleep, physical activity. 
 
 
 
 
Limitation in physical functioning and disability are 
important public health problems because of their 
increasing frequency, linked to population aging, and 
because they are associated with greater risk of morbidity, 
hospitalization and death (1,2) as well as elevated 
healthcare expenditures (3).  
Sleep duration and sleep quality are two of the 
potentially modifiable factors that have been associated 
with physical function impairment, disability and related 
  Volume 10, Number 3; 557-569, June 2019                       
 Campanini MZ., et al                                                                     Sleep and physical function impairment and disability 
Aging and Disease • Volume 10, Number 3, June 2019                                                                               558 
 
factors. Specifically, short sleep duration has been 
associated with bodily pain (4), mobility limitation (5) and 
disability (6), and long sleep duration with decreased gait 
speed (5) and physical function decline (7) in older adults. 
In addition, poor sleep quality has been related to lower 
body functional capacity (5, 8, 9), frailty (10,11) and 
disability (12). 
A better understanding of the association between 
sleep and physical functional impairment and disability 
requires establishing its temporality, an important 
criterion according to Bradford Hill to consider causation 
between two variables (13). All previous studies on this 
matter except three (6,7,10) used a cross-sectional design. 
One of the mentioned studies was a pilot study (6), 
therefore used a small sample size, and another was 
performed only with men (10). The study of Ensrud et al. 
(2012) (7), although using several types of sleep measures 
and a large sample, evaluated only frailty and mortality. 
None of the three studies explored many dimensions of 
functional condition and sleep characteristics (duration 
and quality) using the number of variables used in this 
study. 
Also, sleep quantity and quality should be assessed, 
considering that prospective studies are not consistent if 
physical function outcomes are associated only with sleep 
duration, sleep quality, or both (6,7,10).  Finally, studies 
on this topic should ascertain all domains of physical 
impairment and disability, from self-reported to objective 
performance and disability in activities of daily living, to 
characterize the full impact of sleep on the different stages 
of physical decline. Therefore, the objective of this study 
was to examine the prospective association of sleep 
duration and quality with a range of measures of 
impairment in physical function and disability in older 
adults. To explore this possibility, we used data from two 
independent prospective cohort studies conducted in two 
countries with different lifestyle characteristics: The 
Seniors-ENRICA (Study on Nutrition and Cardiovascular 
Risk Factors in Spain) and the ELSA (English 
Longitudinal Study of Aging) cohorts. 
 
MATERIALS AND METHODS 
 
Study design and participants 
 
The Seniors-ENRICA cohort was established in 2008-
2010 with community-dwelling individuals aged 60 years 
and older, and methods have been reported elsewhere 
(14). The analyses were conducted with 1,773 individuals, 
and, when evaluating each outcome, we excluded 
individuals who had the outcome at baseline. Study 
participants gave written informed consent. The study was 
approved for the Clinical Research Ethics Committee of 
the La Paz University Hospital in Madrid. 
Established in 2002–2003, ELSA is a biennial 
longitudinal study representative of people aged 50 and 
older living in private households in England (15). For 
this study, we used information from 4,885 participants 
aged ≥60 years who participated in wave 4 (2008-2009) 
and were followed through wave 6 (2012-2013). For each 
outcome, we excluded from analyses participants who had 
the outcome at baseline. The National Research Ethics 
Service (MREC/01/2/91) provided the ethical approval 
for ELSA.  
 
Sleep duration and sleep quality 
 
Sleep duration was categorized as short sleep (≤6 h), 
normal sleep (7-8 h) and long sleep (≥9 h) (16). Change 
in sleep duration was calculated by subtracting the 
number of hours/night slept at follow-up from those slept 
at baseline, and classified as no change, increase or 
decrease using 30 minutes as threshold. General quality of 
sleep was classified as ‘poor sleep’ and ‘good sleep’, and 
difficulty falling asleep and awakening during the night 
were also reported. ‘Need to sleep at daytime’ and ‘not 
feeling rested in the morning’ were recorded in Seniors-
ENRICA study, and ‘wake up feeling tired or worn up’ in 
ELSA study. For the analyses, a sleep complaint was 
considered absent when rated as ‘rarely or never’, and was 
deemed to be present when it was reported to occur 
‘sometimes’ or ‘almost always’ in Seniors-ENRICA 
study. In ELSA study, a sleep complaint was considered 
absent when its frequency was rated as ‘not during the last 
month’ or ‘less than once a week’, and was deemed to be 
present when it was reported to occur ‘once or twice a 
week’ or ‘three or more times a week’. Given that the 
simultaneous presence of many sleep complaints is 
common in older adults, and is associated with worse 
health (17), we calculated a ‘dyssomnia score’, whose 
range was from 0 to 4 (Seniors-ENRICA study) or 0-3 
(ELSA study) of the above sleep complaints (12).  
 
Physical function impairment and disability 
 
In the seniors-ENRICA study, individuals were defined as 
having impaired agility when they answered “a lot” to the 
following question from the Rosow and Breslau scale 
(18): “On an average day with your current health, would 
you be limited in bending and kneeling?”, whose 
categories of response were “yes, a lot”, “yes, a little” and 
“not at all”. In the ELSA study, the question used was “Do 
you experience any difficulty stooping, kneeling or 
crouching?”  
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Table 1. Characteristics of the participants in the Seniors-ENRICA study at baseline according to physical function 
impairment and disability. 
 
  
Self-reported 
impaired 
agility 
 
Self-reported 
impaired 
mobility 
 
5-point 
decrease in 
PCS 
 
SPPB score ≤9 
points 
 IADL 
disability  
ADL disability 
(n=1,293) (n=1,475) (n= 1,627) (n=665)  (n=1,308) (n= 1,249) 
 No Yes   No Yes   No Yes   No Yes   No Yes   No Yes 
Participants, n 1099 194  1298 177  1135 492  436 229  1203 105  1120 129 
Female, % 42.0 55.2  43.2 71.75 
 
49.3 56.5 
 
40.8 43.7  48.9 62.9 
 
46.3 67.4 
Age, y 
70.0 
(5.2) 
72.7 
(5.8) 
 70.5 
(5.6) 
73.4 
(6.2)  
71 
(6.0) 
71.7 
(5.9)  
68.7 
(4.6) 
71.2 
(5.8) 
 70.3 
(5.3) 
75.6 
(6.9)  
70.5 
(5.6) 
73.1 
(6.3) 
Educational 
level, %   
 
              
      Primary 41.5 55.1  44.9 62.2  47.3 53.2  39.5 48.0 
 47.6 68.6  48.1 55.8 
      Secondary 30.4 23.2  28.6 20.8  27.8 25.5  29.1 22.7 
 27.0 16.2  25.2 26.4 
      University 28.1 21.7  26.5 17.0 
 
24.9 21.3 
 
31.4 29.3  25.4 15.2 
 
26.7 17.8 
Current 
smokers, % 
9.9 8.3  9.7 6.2 
 
9.3 8.5 
 
11.9 8.3  9.0 12.4 
 
9.7 8.5 
Alcohol intake 
*, %   
 
              
     None 28.1 46.3  31.7 48.7 
 
33.9 40.7 
 
29.4 36.7  33.2 49.5 
 
33.1 42.6 
     Moderate 65.7 49.1  62.8 46.8 
 
61.3 54.0 
 
64.4 55.9  60.8 50.5 
 
61.4 51.2 
     Heavy 6.2 4.6  5.5 4.5 
 
4.8 5.3 
 
6.2 7.4  6.0 0.0 
 
5.5 6.2 
Energy intake, 
Kcal/d 
2083 
(586) 
1951 
(423) 
 2073 
(569) 
1954 
(407)  
2052 
(531) 
2020 
(594)  
2120 
(594) 
2096 
(722) 
 2070 
(571) 
1995 
(466)  
2064 
(576) 
2026 
(416) 
BMI, kg/m2 
27.5 
(3.7) 
29.2 
(4.3) 
 27.9 
(3.8) 
28.9 
(4.4)  
28.4 
(4.2) 
28.7 
(4.3)  
27.8 
(3.9) 
28.3 
(3.8) 
 28.3 
(4) 
29.3 
(5.5)  
28.1 
(4) 
29.8 
(4.7) 
Caffeine 
consumption, 
mg/d 
94 
(137) 
74 
(128) 
 
89 
(1345
) 
86 
(206) 
 
91 
(144) 
82 
(165) 
 
96 
(146) 
112 
(211) 
 92 
(152) 
85 
(123) 
 
91 
(153) 
99 
(150) 
Physical 
activity, MET-
h/wk  
25.3 
(15.1) 
21.4 
(13.1) 
 24.5 
(15.1) 
19.2 
(12.1) 
 
23.4 
(15.1) 
21.0 
(14.3) 
 
26.4 
(16.4) 
24.7 
(14.6) 
 23.6 
(15.2) 
16.5 
(11.3) 
 
23.3 
(15.2) 
19.0 
(13.3) 
Time spent 
watching TV, 
h/wk 
18.4 
(30.7) 
19.8 
(10.6) 
 19.1 
(28.7) 
19.5 
(10.1) 
 
20.4 
(42.0) 
19.9 
(10.4) 
 
19.6 
(47.5) 
18.2 
(9.7) 
 19.9 
(40.8) 
22.4 
(10.5) 
 
20.1 
(42.2) 
20.1 
(10.9) 
Diagnosed 
diseases, %   
 
              
Cardiovascular 
disease † 
4.1 6.2  4.6 6.8 
 
5.4 6.3 
 
3.0 5.2  4.8 9.5 
 
4.6 10.1 
Osteomuscular 
disease ‡ 
34.6 61.9  39.8 65.5 
 
45.9 53.5 
 
35.6 55.5  45.1 61.0 
 
44.9 58.9 
Diabetes 16.8 21.7  18.1 23.2 
 
18.0 22.4 
 
14.7 21.8  17.8 24.8 
 
18.0 24.8 
Cancer 2.6 2.1  2.5 2.8 
 
2.6 2.4 
 
1.8 2.2  2.7 1.9 
 
2.6 1.6 
Depression 5.0 6.2  5.8 8.5 
 
7.4 9.2 
 
3.7 5.2  6.3 14.3 
 
7.1 10.1 
Sleep duration, 
h 
7.0 
(1.2) 
6.8 
(1.4) 
 7.0 
(1.3) 
6.8 
(1.4)   
6.9 
(1.3) 
6.9 
(1.4)  
67.0 
(1.3) 
6.9 
(1.3) 
 6.9 
(1.0) 
6.9 
(1.5)  
6.9 
(1.3) 
6.6 
(1.4) 
Poor overall 
sleep quality, % 
21.5 36.6  23.6 36.7 
 
28.7 32.7 
 
23.4 30.1  28.3 38.1 
 
27.4 41.1 
Dyssomnia 
score ≥1, % 
71.5 78.4   72.3 89.3 
  
74.3 82.5 
  
68.1 78.6   75.1 85.7 
  
75.1 85.3 
 
PCS: physical component summary; SPPB: Short Physical Performance Battery; IADL: instrumental activities of daily living; ADL: basic activities of 
daily living 
For continuous variables, the mean (standard deviation) is reported.  
* Moderate drinker: <40 g/d of alcohol in men and <24 g/d in women. Heavy drinker: ≥40 g/d of alcohol in men and ≥24 g/d in women.  
† Ischemic heart disease, stroke, and heart failure. 
‡ Osteo-arthritis, arthritis, and hip fracture. 
In the Seniors-ENRICA study, mobility disability 
was defined as answering “a lot” to any of the following 
questions from the Rosow and Breslau scale (18): “On an 
average day with your current health, would you be 
limited in the following activities: 1) picking up or 
carrying a shopping bag?; 2) climbing one flight of stairs?; 
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3) walking several city blocks (a few hundred meters)?” 
In the ELSA study, it was defined as an affirmative 
answer to at least one of the following: 1) “Do you 
experience difficulty lifting or carrying weights over 10 
pounds?” 2) “Do you experience difficulty climbing one 
flight of stairs without resting?”, or 3) “Do you experience 
any difficulty walking 1/4 mile unaided?” Physical 
function impairment was evaluated using the Spanish 
version of the physical component summary (PCS) of the 
12-Item Short-Form Health questionnaire (SF-12, version 
2) (19), and the Short Physical Performance Battery 
(SPPB) (1). The PCS consists in a physical health score 
with the following items: physical functioning, role – 
physical, bodily pain, general health. The questionnaire 
uses Likert scales to analyze the intensity or frequency of 
each response. Physical function impairment was deemed 
to exist when the score decreased at least 5 points from 
baseline to follow-up. The Short Physical Performance 
Battery (SPPB) (1) is based on direct, objective measures 
of walking speed, balance, and lower body strength. Each 
measure is scored from 0 to 4, and participants scoring ≤9 
were classified as physically impaired (11). Disability in 
performing instrumental activities of daily living (IADLs) 
(20) and basic activities of daily living (ADLs) (21) were 
also measured in the Seniors-ENRICA study.  
 
 
Table 2. Characteristics of the participants in the ELSA study at baseline according to physical function impairment. 
 
 Self-reported impaired agility  Self-reported impaired mobility 
(n=2,053) (n=2,348) 
  No Yes   No Yes 
Participants, n (weighted) 1542 511  1947 401 
Female, % 46.8 57.0  45.2 62.6 
Age, y 67.9 (6.9) 71.3 (7.9)  68.0 (6.7) 72.7 (8.6) 
Educational level, %      
     No qualifications 25.8 35.5  24.3 36.7 
     Intermediate or foreign 31.3 34.0  32.9 35.5 
     Higher education 42.9 30.5  42.8 27.9 
Current smokers, % 8.1 8.1  7.3 5.3 
Alcohol intake      
     0-2 times/month 31.6 41.1  31.8 41.1 
     1-4 times/week 42.0 35.7  41.1 37.0 
     5-7 times/week 26.3 23.2  27.1 21.9 
BMI, kg/m2 26.9 (4.0) 28.3 (5.0)  27.6 (4.3) 28.7 (4.9) 
Physical activity, %      
 hardly ever/never 27.1 15.2  27.1 11.9 
 1-3 times/ month 55.9 52.7  56.7 60.2 
 once/ week 14.3 28.1  14.3 24.3 
 > once/week 2.7 4.1  2.0 3.5 
Time spent watching TV, h/wk 41.1 (33.5) 46.5 (36.9)  41.4 (32.2) 45.0 (36.7) 
Diagnosed diseases, %      
 Cardiovascular disease * 0.7 1.4  0.8 0.9 
 Osteomuscular disease † 15.2 28.8  19.7 37.4 
 Diabetes 7.5 12.9  7.3 12.4 
 Cancer 1.9 2.3  2.1 3.6 
 Depression 4.9 7.6  5.2 7.1 
Sleep duration, h 7.0 (1.1) 6.9 (1.4)  7.0 (1.2) 6.8 (1.4) 
Poor overall sleep quality, % 12.6 20.7  13.7 22.0 
Dyssomnia score ≥1, % 67.5 77.2  69.3 77.9 
 
 
For continuous variables, the mean (standard deviation) is reported.  
* Ischemic heart disease, stroke, and heart failure. 
† Osteo-arthritis, arthritis, and hip fracture.  
Other variables 
 
At baseline in both cohorts, self-reported information was 
obtained on age, sex, educational status and tobacco 
consumption. Weight and height were measured in 
standardized conditions (22), and the body mass index 
(BMI) was calculated as weight in kg divided by square 
height in m and classified as <25, 25-29.9 and ≥30 kg/m2. 
Participants also reported the following physician-
diagnosed diseases: cardiovascular disease (ischemic 
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heart disease, stroke and heart failure), diabetes, cancer, 
depression requiring pharmacological treatment, and 
osteomuscular diseases (osteoarthritis, arthritis and hip 
fracture). Sedentary behavior was approximated by the 
time (hours/week) spent watching TV.  
In the Seniors-ENRICA study, physical activity 
during leisure time (metabolic equivalent hours/week) 
was ascertained with the EPIC-cohort questionnaire, 
validated in Spain (23). Total energy intake (kcal/d), 
caffeine and alcohol intake were estimated from a 
validated diet history and standard food composition 
tables (24). Alcohol consumption was categorized as no 
drinker, moderate drinker and heavy drinker (≥40 g/d of 
alcohol in men and ≥24 g/d in women) (25). In the ELSA 
study, participants informed the weekly frequency of 
alcohol consumption. Cognitive function was assessed in 
a subsample of participants of the Seniors-ENRICA study 
with the Mini-Mental State Examination (MMSE) (26). 
Information on sleeping medication (yes or no) was also 
collected in the Seniors-ENRICA study.  
 
 
 
Table 3. Odds ratios (95% confidence interval)a for the association between change in sleep duration and physical 
function impairment during a 2.8 year follow-up in Seniors-ENRICA study and a 2 year follow-up in the ELSA study 
of older adults. 
 
  No changeb Decrease ≥30 min Increase ≥30 min 
Self-reported impaired agility    
     Seniors-ENRICA study, N/n cases 458/51 350/56 485/87 
        Age- and sex-adjusted  1.00 1.43 (0.94; 2.17) 1.67 (1.14; 2.44) 
        Multivariable modelc 1.00 1.37 (0.85; 2.21) 1.23 (0.80; 1.89) 
        Multivariable modeld 1.00 1.35 (0.84; 2.19) 1.21 (0.78; 1.87) 
        Multivariable modele 1.00 1.35 (0.83; 2.19) 1.24 (0.80; 1.92) 
      ELSA study, N/n cases 741/183 641/164 671/164 
        Age- and sex-adjusted 1.00 1.01 (0.80; 1.28) 0.91 (0.71; 1.16) 
        Multivariable modelf 1.00 1.01 (0.78; 1.29) 0.84 (0.65; 1.10) 
        Multivariable modelg 1.00 0.98 (0.76; 1.27) 0.83 (0.63; 1.08) 
        Multivariable modelh 1.00 0.96 (0.74; 1.24) 0.82 (0.63; 1.07) 
Self-reported impaired mobility    
      Seniors-ENRICA study, N/n cases 511/46 410/59 554/72 
        Age- and sex-adjusted 1.00 1.53 (1.00; 2.34) 1.42 (0.95; 2.13) 
        Multivariable modelc 1.00 1.57 (0.97; 2.54) 1.32 (0.83; 2.09) 
        Multivariable modeld 1.00 1.57 (0.97; 2.55) 1.31 (0.83; 2.08) 
        Multivariable modele 1.00 1.50 (0.92; 2.45) 1.31 (0.82; 2.08) 
      ELSA study, N/n cases  845/127 747/141 756/133 
        Age- and sex-adjusted 1.00 1.33 (1.02; 1.72) 1.15 (0.88; 1.52) 
        Multivariable modelf 1.00 1.27 (0.96; 1.67) 1.04 (0.77; 1.40) 
        Multivariable modelg 1.00 1.26 (0.95; 1.66) 1.02 (0.76; 1.38) 
        Multivariable modelh 1.00 1.22 (0.92; 1.62) 1.01 (0.75; 1.36) 
5-point decrease in PCSi, N/n cases (Seniors-
ENRICA study) 
557/163 457/143 613/186 
        Age- and sex-adjusted 1.00 1.10 (0.83; 1.45) 1.05 (0.82; 1.37) 
        Multivariable modelc 1.00 1.12 (0.82; 1.53) 0.98 (0.73; 1.31) 
        Multivariable modeld 1.00 1.14 (0.83; 1.56) 0.97 (0.72; 1.30) 
        Multivariable modele 1.00 1.12 (0.81; 1.54) 0.97 (0.72; 1.30) 
Impaired lower extremity functionj, N/n cases 
(Seniors-ENRICA study) 
237/75 184/66 244/88 
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        Age- and sex-adjusted 1.00 1.11 (0.73; 1.69) 1.23 (0.83; 1.81) 
        Multivariable modelc 1.00 1.18 (0.75; 1.87) 1.24 (0.81; 1.90) 
        Multivariable modeld 1.00 1.17 (0.74; 1.85) 1.28 (0.83; 1.97) 
        Multivariable modele 1.00 1.14 (0.72; 1.81) 1.29 (0.84; 1.99) 
IADL disability, N/n cases (Seniors-ENRICA 
study) 
445/29 374/34 489/42 
        Age- and sex-adjusted 1.00 1.20 (0.70; 2.05) 1.13 (0.68; 1.88) 
        Multivariable modelc 1.00 1.04 (0.58; 1.90) 1.08 (0.61; 1.89) 
        Multivariable modeld 1.00 1.05 (0.58; 1.92) 1.10 (0.62; 1.94) 
        Multivariable modele 1.00 1.04 (0.57; 1.90) 1.11 (0.63; 1.96) 
ADL disability, N/n cases (Seniors-ENRICA 
study) 
424/38 353/36 472/55 
        Age- and sex-adjusted 1.00 1.01 (0.62; 1.65) 1.25 (0.80; 1.95) 
        Multivariable modelc 1.00 1.13 (0.67; 1.90) 1.18 (0.73; 1.90) 
        Multivariable modeld 1.00 1.14 (0.68; 1.91) 1.18 (0.73; 1.90) 
        Multivariable modele 1.00 1.13 (0.67; 1.91) 1.19 (0.74; 1.92) 
 
PCS: physical component summary; SPPB: Short Physical Performance Battery; IADL: instrumental activities of daily living; ADL: basic 
activities of daily living 
aLogistic regression models. 
bChanges < 30 min. 
cAdjusted for educational level (primary, secondary, university), BMI at baseline and change (continuous, kg/m2), change in tobacco consumption 
(never smoker, former smoker in 2012, smoker in 2012 who quit in 2015, and current smoker in 2015), baseline adherence to the Mediterranean 
diet (MEDAS score, tertiles), baseline intakes of energy (kcal/day, tertiles), caffeine (g/day, tertiles) and alcohol (none, moderate, heavy drinker), 
baseline and change in time spent watching TV(h/wk, tertiles), baseline diagnosed diseases (cardiovascular diseases, diabetes, cancer, depression 
and osteomuscular diseases) and baseline sleep duration (≤6, 7-8, ≥9 h).  
dAdditionally adjusted for baseline and change in physical activity (METs*hours/week, tertiles). 
eAdditionally adjusted for general sleep quality (good, poor) and for the dyssomnia score (0, 1, 2, 3-4). 
fAdjusted for educational level (no qualifications, intermediate or foreign, higher education), BMI at baseline and change (continuous, kg/m2), 
change in tobacco consumption (never smoker, former smoker in 2008, smoker in 2008 who quit in 2010, and current smoker in 2010), baseline 
intake of alcohol (5-7 times/week, 1-4 times/week, 0-2 times/month), baseline and change in time spent watching TV(h/wk, tertiles), baseline 
diagnosed diseases (cardiovascular diseases, diabetes, cancer, depression and osteomuscular diseases) and baseline sleep duration (≤6, 7-8, ≥9 h).  
gAdditionally adjusted for baseline physical activity (>once/week, once/week, 1-3 times/ month, hardly ever/never). 
hAdditionally adjusted for general sleep quality (good, poor) and for the dyssomnia score (0, 1, 2, 3). 
iAdditionally adjusted for basal PCS 
jSPPB score ≤9 points. 
Statistical analysis 
 
We used logistic regression models to examine the 
association between changes in sleep duration and 
incident outcomes, using no change in sleep as reference. 
Likewise, logistic regression was used to assess the 
association of general sleep quality, each individual sleep 
complaint, and the dyssomnia score at baseline with the 
risk of physical function impairment and disability at 
follow-up. We also investigated the linear dose-response 
associations by using the number of sleep complaints as a 
continuous variable in the models. Study results were 
summarized with odds ratios (OR) and their 
corresponding 95% confidence interval (CI). 
We built four logistic models. The first one was 
adjusted for age and sex, and the second one was further 
adjusted for educational level, lifestyle variables and 
morbidity. Because physical activity may play a key role 
on the development of physical function impairment (27), 
a third model was additionally adjusted for this variable. 
Lastly, a fourth model was additionally adjusted for sleep 
variables: analyses of changes in sleep duration were 
adjusted for general sleep quality and for the dyssomnia 
score at baseline, and analyses of general sleep quality and 
dyssomnia score were adjusted for changes in sleep 
duration. 
We formally tested interaction between change in 
sleep duration and sleep quality by using likelihood-ratio 
tests, which compared models with and without cross-
product interaction terms, finding no interaction between 
these two variables. Differences between men and women 
in the study associations were also tested with likelihood-
ratio tests. As no interactions between sex and sleep 
variables in relation to physical function impairment and 
disability were found, results are presented for women and 
men combined. Statistical significance was set at 2-tailed 
p<0.05. The statistical analyses were performed using 
Stata software (version 13.0; Stata Corp., College 
Station). 
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Table 4. Odds ratios (95% confidence interval)a for the association between poor general sleep quality and the dyssomnia 
score and physical function impairment during a 2.8-year follow-up in Seniors-ENRICA study and a 2-year follow-up in 
the ELSA study of older adults. 
 
 
Poor general 
sleep quality 
Dyssomnia score 
   0 1 2 3-4 b 
p for 
trend 
Self-reported impaired agility       
      Seniors-ENRICA study, N/n cases 307/71 355/42 449/64 338/51 151/37  
        Age- and sex-adjusted 2.11 (1.50; 2.96) 1.00 1.16 (0.76; 1.77) 1.09 (0.70; 1.71) 1.97 (1.19; 3.28) 0.04 
        Multivariable modelc 1.89 (1.28; 2.78) 1.00 0.96 (0.60; 1.54) 1.02 (0.62; 1.69) 1.76 (0.99; 3.11) 0.09 
        Multivariable modeld 1.94 (1.31; 2.87) 1.00 0.95 (0.59; 1.53) 1.00 (0.61; 1.66) 1.74 (0.98; 3.08) 0.10 
        Multivariable modele 1.93 (1.30; 2.86) 1.00 0.94 (0.59; 1.52) 0.99 (0.60; 1.64) 1.69 (0.95; 3.01) 0.13 
      ELSA study, N/n cases 299/106 618/117 438/122 686/89 520/114  
        Age- and sex-adjusted 1.85 (1.42; 2.41) 1.00 1.42 (1.10; 1.84) 1.60 (1.20; 2.14) 2.53 (1.75; 3.65) <0.001 
        Multivariable modelf 1.65 (1.25; 2.17) 1.00 1.35 (1.03; 1.76) 1.55 (1.14; 2.09) 2.12 (1.44; 3.11) <0.001 
        Multivariable modelg 1.61 (1.22; 2.12) 1.00 1.35 (1.03; 1.76) 1.51 (1.11; 2.04) 2.06 (1.40; 3.03) <0.001 
        Multivariable modelh 1.65 (1.24; 2.18) 1.00 1.34 (1.03; 1.75) 1.53 (1.13; 2.06) 2.10 (1.43; 3.00) <0.001 
Self-reported impaired mobility 371/65 379/19 499/45 408/74 189/39  
     Seniors-ENRICA study, N/n cases       
        Age- and sex-adjusted 1.70 (1.20; 2.40) 1.00 1.75 (0.99; 3.06) 3.24 (1.89; 5.55) 3.33 (1.83; 6.04) <0.001 
        Multivariable modelc 1.39 (0.94; 2.06) 1.00 1.37 (0.76; 2.48) 2.32 (1.31; 4.11) 2.29 (1.20; 4.36) 0.002 
        Multivariable modeld 1.45 (0.98; 2.16) 1.00 1.34 (0.74; 2.42) 2.30 (1.30; 4.09) 2.31 (1.21; 4.41) 0.001 
        Multivariable model e 1.46 (0.98; 2.17) 1.00 1.33 (0.73; 2.40) 2.24 (1.26; 3.99) 2.28 (1.19; 4.37) 0.002 
     ELSA study, N/n cases 354/88 805/200 192/73 917/142 226/57  
        Age- and sex-adjusted 1.79 (1.35; 2.36) 1.00 1.31 (0.97; 1.75) 1.92 (1.40; 2.62) 2.11 (1.41; 3.14) <0.001 
        Multivariable modelf 1.60 (1.19; 2.15) 1.00 1.25 (0.93; 1.69) 1.82 (1.30; 2.53) 1.79 (1.18; 2.71) <0.001 
        Multivariable modelg 1.58 (1.18; 2.13) 1.00 1.25 (0.92; 1.69) 1.79 (1.28; 2.50) 1.76 (1.16; 2.67) <0.001 
        Multivariable modelh 1.59 (1.18; 2.15) 1.00 1.25 (0.92; 1.69) 1.78 (1.28; 2.49) 1.76 (1.16; 2.68) <0.001 
5-point decrease in PCSi, N/n cases 
(Seniors-ENRICA study) 
487/161 378/86 522/168 460/149 267/89  
        Age- and sex-adjusted 1.47 (1.15; 1.88) 1.00 1.67 (1.23; 2.28) 1.70 (1.23; 2.34) 2.17 (1.48; 3.17) <0.001 
        Multivariable modelc 1.29 (0.98; 1.69) 1.00 1.56 (1.12; 2.18) 1.55 (1.09; 2.20) 1.82 (1.19; 2.76) 0.008 
        Multivariable modeld 1.38 (1.05; 1.81) 1.00 1.52 (1.09; 2.14) 1.53 (1.07; 2.19) 1.87 (1.22; 2.86) 0.006 
        Multivariable modele 1.39 (1.05; 1.83) 1.00 1.52 (1.09; 2.14) 1.54 (1.08; 2.20) 1.89 (1.23; 2.89) 0.005 
Impaired lower extremity functionj, 
N/n cases (Seniors-ENRICA study) 
171/69 188/49 231/74 179/78 67/28  
        Age- and sex-adjusted 1.46 (1.00; 2.12) 1.00 1.30 (0.84; 2.02) 2.00 (1.27; 3.16) 1.94 (1.06; 3.56) 0.002 
        Multivariable modelc 1.28 (0.85; 1.92) 1.00 1.14 (0.72; 1.81) 1.90 (1.16; 3.12) 1.38 (0.71; 2.68) 0.04 
        Multivariable modeld 1.26 (0.84; 1.89) 1.00 1.15 (0.72; 1.84) 1.91 (1.16; 3.14) 1.36 (0.70; 2.65) 0.04 
        Multivariable modele 1.25 (0.83; 1.88) 1.00 1.16 (0.73; 1.84) 1.91 (1.16; 3.14) 1.34 (0.68; 2.60) 0.05 
IADL disability, N/n cases (Seniors-
ENRICA study) 
380/40 315/15 433/32 358/34 202/24  
        Age- and sex-adjusted 1.72 (1.11; 2.68) 1.00 1.38 (0.72; 2.64) 1.59 (0.83; 3.05) 1.96 (0.97; 3.96) 0.05 
        Multivariable modelc 1.59 (0.98; 2.58) 1.00 1.19 (0.60; 2.37) 1.39 (0.69; 2.78) 1.37 (0.63; 2.95) 0.37 
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        Multivariable modeld 1.57 (0.96; 2.54) 1.00 1.14 (0.57; 2.28) 1.30 (0.65; 2.64) 1.25 (0.57; 2.71) 0.04 
        Multivariable modele 1.59 (0.97; 2.59) 1.00 1.14 (0.57; 2.29) 1.30 (0.64; 2.64) 1.26 (0.58; 2.75) 0.51 
ADL disability, N/n cases (Seniors-
ENRICA study) 
360/53 298/19 415/43 355/41 181/26  
        Age- and sex-adjusted 1.71(1.16; 2.53) 1.00 1.55 (0.88; 2.74) 1.50 (0.84; 2.67) 1.74 (0.91; 3.30) 0.14 
        Multivariable modelc 1.76 (1.16; 2.67) 1.00 1.42 (0.79; 2.55) 1.39 (0.76; 2.55) 1.49 (0.75; 2.95) 0.31 
        Multivariable modeld 1.75 (1.15; 2.67) 1.00 1.39 (0.77; 2.51) 1.36 (0.74; 2.51) 1.44 (0.72; 2.87) 0.51 
        Multivariable modele 1.73 (1.14; 2.64) 1.00 1.38 (0.77; 2.49) 1.35 (0.73; 2.48) 1.40 (0.70; 2.80) 0.42 
 
 
PCS: physical component summary; SPPB: Short Physical Performance Battery; IADL: instrumental activities of daily living; ADL: basic activities 
of daily living 
aLogistic regression models. 
b3 sleep complaints For ELSA study. 
cAdjusted for educational level (primary, secondary, university), BMI at baseline and change (continuous, kg/m2), change in tobacco consumption 
(never smoker, former smoker in 2012, smoker in 2012 who quit in 2015, and current smoker in 2015), baseline adherence to the Mediterranean diet 
(MEDAS score, tertiles), baseline intakes of energy (kcal/day, tertiles), caffeine (g/day, tertiles) and alcohol (none, moderate, heavy drinker), 
baseline and change in time spent watching TV(h/wk, tertiles) and baseline diagnosed diseases (cardiovascular diseases, diabetes, cancer, depression 
and osteomuscular diseases). 
dAdditionally adjusted for baseline and change in physical activity (METs*hours/week, tertiles). 
eAdditionally adjusted for change in sleep duration (no change, decrease, increase). 
fAdjusted for educational level (no qualifications, intermediate or foreign, higher education), BMI at baseline and change (continuous, kg/m2), 
change in tobacco consumption (never smoker, former smoker in 2008, smoker in 2008 who quit in 2010, and current smoker in 2010), baseline 
intake of alcohol (5-7 times/week, 1-4 times/week, 0-2 times/month), baseline and change in time spent watching TV(h/wk, tertiles), baseline 
diagnosed diseases (cardiovascular diseases, diabetes, cancer, depression and osteomuscular diseases) and baseline sleep duration (≤6, 7-8, ≥9 h).  
gAdditionally adjusted for baseline physical activity (>once/week, once/week, 1-3 times/ month, hardly ever/never). 
hAdditionally adjusted for change in sleep duration (no change, decrease, increase). 
iAdditionally adjusted for basal PCS. 
jSPPB score ≤9 points. 
RESULTS 
 
During a mean follow-up of 2.8 years in the Seniors-
ENRICA study and 2 years in the ELSA study, the 
incidence of limitations in agility in each cohort was 
15.0% and 25.0%; and mobility disability was 12.0% and 
17.0%, respectively. In the Seniors-ENRICA study, the 
incidence of impaired overall physical performance was 
30.2%. Moreover, 34.0% of the individuals developed 
impaired lower extremity function at the end of follow-
up, 8% developed IADL disability and 10.3% developed 
ADL disability.  
Tables 1 and 2 show the sociodemographic, 
behavioral and clinical characteristics of the participants 
in the Seniors-ENRICA study and the ELSA study at 
baseline according to categories of physical function 
impairment or disability. Compared to those not impaired, 
those with limitation in any of the seven studied domains 
were older, mostly women, and with lower educational 
level. Also, they had higher BMI, and more frequently had 
cardiovascular and osteomuscular diseases, diabetes and 
depression. In the Seniors-ENRICA study, those 
participants also did less physical activity.  
Mean (SD) sleep duration in the study participants 
was 6.9 (1.4) and 6.9 (1.3) h/night at baseline and 7.0 (1.4) 
and 6.9 (1.3) h/night at follow-up in Seniors-ENRICA 
study and in ELSA study, respectively. During the follow-
up, 500 (28.2%) and 1031 (31.0%) persons decreased 
their sleep duration at least 30 minutes/night in Seniors-
ENRICA study and in ELSA study, respectively. In 
addition, 676 (38.1%) and 1086 (33.7%) persons reported 
an increase of at least 30 minutes/night in Seniors-
ENRICA study and in ELSA study, respectively. No 
association was seen among decrease or increase in the 
sleep duration and the studied outcomes (Table 3). 
The associations between sleep quality and study 
outcomes are shown in Table 4. Overall, in Senior-
ENRICA study, 29% of the participants reported poor 
general sleep quality, and 77% had at least one of the four 
sleep complaints considered, 44% at least two, and 17% 
three or four. In ELSA study, 20% of the participants 
reported poor general sleep quality, and 36% had at least 
one of the three sleep complaints, 25% at least two, and 
14% all three. In both studies, poor general sleep quality 
was associated with higher risk of impaired agility [OR: 
1.93 (95% CI: 1.30-2.86) in Seniors-ENRICA and 1.65 
(1.24-2.18) in ELSA study] and mobility disability [1.46 
(0.98-2.17) in Seniors-ENRICA and 1.59 (1.18-2.15) in 
ELSA study]. Poor general sleep quality was also 
associated with decreased PCS [1.39 (1.05-1.83)], IADL 
disability [1.59 (0.97-2.59)] and ADL disability [1.73 
(1.14-2.64)].  
In Seniors-ENRICA study, compared to those with no 
sleep complaints, participants with 2 and 3-4 complaints 
had greater risk of mobility disability [2.24 (1.26-3.99) 
and 2.28 (1.19-4.37), respectively; p-trend=0.002], 
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decreased PCS [1.54 (1.08-2.20) and 1.89 (1.23-2.89), 
respectively; p-trend=0.005] and impaired lower 
extremity function [1.91 (1.16-3.14) and 1.34 (0.68-2.60), 
respectively, p-trend=0.05]. Additional adjustment for 
sleeping medication did not materially change the results 
(data not shown). The associations between the individual 
components of the dyssomnia score and the studied 
outcomes in Seniors-ENRICA study are shown in Table 
5. Finally, as a sensitivity analyses, we replicated the 
regression models with further adjustment for cognitive 
impairment and the results did not materially change. In 
ELSA study, compared to those with no sleep complaints, 
participants with 2 and 3 complaints had greater risk of 
impaired agility [1.53 (1.13-2.06) and 2.10 (1.43-3.00), 
respectively; p-trend<0.001] and mobility disability [1.78 
(1.28-2.49) and 1.76 (1.16-2.68), respectively; p-
trend<0.001]. The associations between the individual 
components of the dyssomnia score and the studied 
outcomes in ELSA study are shown in Table 6.  
 
 
Table 5. Odds ratios (95% confidence interval) * for the association between indicators of poor sleep quality and physical function 
impairment during a 2.8-year follow-up in Seniors-ENRICA study. 
 
  
Difficulty  
falling asleep  
Awakening  
during the night 
Need to sleep  
at daytime 
Not feeling rested 
in the morning 
Self-reported impaired agility, N/n 
cases 394/72 800/126 175/32 241/57 
      Age- and sex-adjusted 1.19 (0.85; 1.66) 1.07 (0.77; 1.48) 1.32 (0.86; 2.02) 1.86 (1.30; 2.67) 
      Multivariable model†  1.20 (0.82; 1.74) 1.02 (0.71; 1.48) 1.31 (0.81; 2.11) 1.75 (1.17; 2.62) 
      Multivariable model‡ 1.19 (0.82; 1.74) 1.01 (0.70; 1.46) 1.29 (0.80; 2.08) 1.75 (1.17; 2.63) 
      Multivariable model§ 1.17 (0.80; 1.71) 1.00 (0.69; 1.44) 1.25 (0.77; 2.03) 1.75 (1.16; 2.63) 
Self-reported impaired mobility, 
N/n cases 483/87 933/136 222/44 282/52 
      Age- and sex-adjusted 1.59 (1.14; 2.22) 1.80 (1.24; 2.63) 2.04 (1.38; 3.02) 1.59 (1.10; 2.29) 
      Multivariable model†  1.30 (0.90; 1.89) 1.44 (0.96; 2.16) 1.75 (1.12; 2.71) 1.50 (1.00; 2.27) 
      Multivariable model‡ 1.33 (0.91; 1.93) 1.42 (0.94; 2.14) 1.74 (1.12; 2.71) 1.53 (1.01; 2.30) 
      Multivariable model§ 1.31 (0.90; 1.90) 1.40 (0.93; 2.10) 1.74 (1.11; 2.71) 1.54 (1.02; 2.33) 
5-point decrease in PCS||, N/n cases 593/209 1070/325 257/86 383/120 
      Age- and sex-adjusted 1.5 (1.19; 1.90) 1.41 (1.11; 1.78) 1.31 (0.97; 1.76) 1.29 (0.98; 1.68) 
      Multivariable model†  1.37 (1.06; 1.77) 1.27 (0.98; 1.65) 1.24 (0.9; 1.71) 1.21 (0.90; 1.63) 
      Multivariable model‡ 1.39 (1.07; 1.81) 1.26 (0.97; 1.63) 1.22 (0.88; 1.68) 1.27 (0.94; 1.71) 
      Multivariable model§ 1.40 (1.07; 1.81) 1.26 (0.97; 1.64) 1.23 (0.88; 1.70) 1.28 (0.95; 1.72) 
Impaired lower extremity function¶, 
N/n cases  202/88 390/143 88/37 121/52 
      Age- and sex-adjusted 1.71 (1.18; 2.47) 1.21 (0.87; 1.70) 1.35 (0.84; 2.16) 1.55 (1.03; 2.35) 
      Multivariable model†  1.64 (1.10; 2.45) 1.10 (0.77; 1.58) 1.23 (0.74; 2.04) 1.29 (0.82; 2.02) 
      Multivariable model‡ 1.65 (1.10; 2.46) 1.11 (0.77; 1.59) 1.21 (0.73; 2.01) 1.26 (0.81; 1.98) 
      Multivariable model§ 1.64 (1.09; 2.45) 1.10 (0.77; 1.58) 1.19 (0.71; 1.98) 1.27 (0.81; 1.99) 
IADL disability, N/n cases  467/50 838/78 198/20 293/30 
      Age- and sex-adjusted 1.27 (0.83; 1.97) 1.49 (0.93; 2.39) 1.33 (0.78; 2.26) 1.31 (0.82; 2.09) 
      Multivariable model†  1.09 (0.69; 1.73) 1.38 (0.84; 2.30) 1.16 (0.65; 2.07) 1.06 (0.64; 1.76) 
      Multivariable model‡ 1.07 (0.67; 1.71) 1.31 (0.79; 2.18) 1.10 (0.61; 1.97) 1.02 (0.61; 1.70) 
      Multivariable model§ 1.07 (0.67; 1.71) 1.31 (0.79; 2.18) 1.11 (0.62; 1.99) 1.03 (0.61; 1.71) 
ADL disability, N/n cases 436/56 798/96 196/18 278/41 
      Age- and sex-adjusted 1.15 (0.78; 1.70) 1.52 (1.00; 2.31) 0.82 (0.48; 1.40) 1.47 (0.98; 2.22) 
      Multivariable model†  1.14 (0.76; 1.72) 1.46 (0.94; 2.26) 0.67 (0.38; 1.18) 1.43 (0.92; 2.20) 
      Multivariable model‡ 1.07 (0.67; 1.71) 1.44 (0.93; 2.23) 0.65 (0.37; 1.14) 1.40 (0.91; 2.17) 
      Multivariable model§ 1.12 (0.74; 1.69) 1.43 (0.92; 2.21) 0.64 (0.36; 1.14) 1.39 (0.89; 2.15) 
 
* Logistic regression models. 
† Adjusted for educational level (primary, secondary, university), BMI at baseline and change (continuous, kg/m2), change in tobacco consumption 
(never smoker, former smoker in 2012, smoker in 2012 who quit in 2015, and current smoker in 2015), baseline adherence to the Mediterranean diet 
(MEDAS score, tertiles), baseline intakes of energy (kcal/day, tertiles), caffeine (g/day, tertiles) and alcohol (none, moderate, heavy drinker), baseline 
and change in time spent watching TV(h/wk, tertiles) and baseline diagnosed diseases (cardiovascular diseases, diabetes, cancer, depression and 
osteomuscular diseases). 
‡ Additionally adjusted for baseline and change in physical activity (METs*hours/week, tertiles). 
§ Additionally adjusted for change in sleep duration (no change, decrease, increase). 
|| Additionally adjusted for basal PCS. 
¶ SPPB score ≤9 points. 
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Table 6. Odds ratios (95% confidence interval)* for the association between indicators of poor sleep quality and physical 
function impairment during a 2 year follow-up in the ELSA study of older adults. 
 
  
Poor sleep 
quality 
Difficulty  
falling asleep  
Awakening  
during the night Waking up tired Restless sleep 
Self-reported impaired 
agility, N/n cases 299/106 453/1389 1308/364 496/161 539/174 
        Age- and sex-
adjusted 1.85 (1.42;2.41) 1.37 (1.08;1.74) 1.52 (1.23;1.89) 1.64 (1.31;2.05) 1.64 (1.31;2.04) 
        Multivariable 
model † 1.65 (1.25;2.17) 1.29 (1.00;1.65) 1.47 (1.17;1.84) 1.49 (1.18;1.89) 1.49 (1.18;1.88) 
        Multivariable 
model ‡ 1.61 (1.22;2.12) 1.27 (0.99;1.63) 1.46 (1.16;1.83) 1.44 (1.13;1.83) 1.47 (1.16;1.85) 
        Multivariable 
model § 1.65 (1.24;2.18) 1.29 (1.00;1.66) 1.47 (1.17;1.85) 1.46 (1.14;1.85) 1.49 (1.18;1.89) 
Self-reported impaired 
mobility, N/n cases 354/88 530/117 1537/291 567/1354 643/145 
        Age- and sex-
adjusted 1.79 (1.35;2.36) 1.30 (1.01;1.68) 1.49 (1.17;1.90) 1.82 (1.43;2.31) 1.57 (1.24;1.99) 
        Multivariable 
model † 1.60 (1.19;2.15) 1.23 (0.94;1.61) 1.39 (1.08;1.80) 1.67 (1.30;2.16) 1.46 (1.14;1.88) 
        Multivariable 
model ‡ 1.58 (1.18;2.13) 1.23 (0.94;1.61) 1.37 (1.06;1.77) 1.64 (1.27;2.13) 1.44 (1.12;1.84) 
        Multivariable 
model § 1.59 (1.18;2.15) 1.23 (0.94;1.61) 1.37 (1.06;1.77) 1.64 (1.27;2.13) 1.44 (1.12;1.86) 
 
* Logistic regression models. 
† Adjusted for educational level (no qualifications, intermediate or foreign, higher education), BMI at baseline and change (continuous, kg/m2), change 
in tobacco consumption (never smoker, former smoker in 2008, smoker in 2008 who quit in 2010, and current smoker in 2010), baseline intake of 
alcohol (5-7 times/week, 1-4 times/week, 0-2 times/month), baseline and change in time spent watching TV(h/wk, tertiles), baseline diagnosed diseases 
(cardiovascular diseases, diabetes, cancer, depression and osteomuscular diseases) and baseline sleep duration (≤6, 7-8, ≥9 h).  
‡ Additionally, adjusted for baseline physical activity (>once/week, once/week, 1-3 times/ month, hardly ever/never). 
§ Additionally adjusted for change in sleep duration (no change, decrease, increase). 
DISCUSSION 
 
In this prospective study of community-dwelling older 
adults from two European countries, general poor sleep 
quality and several sleep complaints were associated with 
higher risk of physical function impairment and disability. 
Regarding the prospective relation between sleep duration 
and quality and function outcomes, other studies diverge 
on the associations found.  For instance, the study of 
Ensrud et al. (2012) (10) evaluated several sleep 
parameters, and found association between sleep quality 
variables and frailty and mortality at follow-up. Such 
associations did not occur for sleep duration. On the other 
hand, Lorenz et al. (2014) (6) evaluated only sleep 
duration and associated it with preclinical disability and 
mobility difficulty. The study of Stenholm et al. (2011) 
(7) also found relation between long sleep duration and 
long time spent in bed and decline in physical 
performance measured by the SPPB and subjective 
mobility disability. 
The effect of sleep on health in the older population 
has been largely studied (28,29). However, the effect of 
changes in sleep duration over time is less known. 
Previous studies have found an association between 
changes in sleep (both increased and decreased) and 
higher risk of diabetes (30), lower cognitive function (31) 
and higher risk in premature mortality (32). Our results 
showed some tendency for both reduced and increased 
sleep to be associated with limited agility and mobility 
disability, but statistical significance was not reached 
possibly because of insufficient statistical power. Future 
research should assess further this hypothesis.   
Individual sleep complaints had already shown a 
detrimental impact on physical function. For instance, 
poor general sleep quality was associated with impaired 
mobility (9) and frailty (10), and insomnia symptoms 
were associated with impaired mobility (6). Daytime 
complaints were linked to higher risk of social outcome, 
general productivity, vigilance, activity level, and global 
assessment of functional status of the Functional 
Outcomes of Sleepiness Questionnaire (FOSQ) (8), and 
frailty (11). When combining the sleep complaints, we 
found evidence of a cumulative effect on the risk of 
impaired agility, mobility disability, decreased PCS and 
impaired lower extremity function. Nighttime and 
daytime sleep symptoms are interconnected, mainly 
because sleep disturbances may cause daytime sleepiness 
(28,29). Nevertheless, nighttime symptoms are sometimes 
unrecognized or even considered normal in older adults, 
and some sleep disorders do not always cause full arousal 
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(33). Our results suggest that isolated sleep complaints 
may not be able to characterize sleep quality and its 
impact on physical function. On the other hand, the single 
question on ‘self-reported poor general sleep quality’ was 
also a predictor of physical function impairment and 
disability, although the association was weaker than that 
observed for the dysomnia score. Corroborating, similar 
single questions about sleep quality were already 
associated with mobility disability (9) and loss of muscle 
mass (34).    
Some mechanisms might explain the association 
between sleep and physical function impairment and 
disability. For example, poor sleep quality affect 
hypothalamus-pituitary-adrenal axis activity (35), 
resulting in hormone imbalances, such reduced growth 
hormone (36) and testosterone levels (37), and increased 
cortisol (38), favoring proteolysis and modifying body 
composition toward skeletal muscle loss (34). 
Furthermore, both sleep duration and quality play an 
important role on inflammation (39,40), and an elevated 
level of inflammation has been associated with poorer 
physical function in older adults (41).  
Our study has several strengths, including the use of 
two distinct prospective cohorts from countries with 
different lifestyles, and that the results were robust after 
adjustment for many potential confounders, including 
physical activity during leisure time. Although we have 
used two cohorts, the totality of function variables was 
evaluated only in Seniors-ENRICA study. Limitations 
include the use of self-reported sleep duration and quality, 
which may be affected by recall and social desirability 
biases. However, the use of self-reported measures of 
sleep is habitual in large prospective studies due to its 
low-costs and simplicity. In addition, although objective 
measures of sleep duration are more accurate (42), 
information related to personal perception of sleep can 
only be achieved with self-reported data (43). Another 
limitation was the use of self-reported information for 
mobility disability, agility and the PCS; however, we 
combined it with a measure of lower extremity 
performance, in order to achieve a more complete 
assessment of physical function impairment. The 
relatively low incidence of the outcomes during the 
follow-up period may have limited the statistical power to 
detect the associations between sleep and some of the 
outcomes. Finally, as in most observational studies, 
certain residual confounding cannot be ruled out, despite 
adjustment for many variables.  
Conclusions 
In conclusion, we found that accumulation of sleep 
complains in older individuals independently predict 
physical function impairment and disability. Screening 
sleep characteristics among the older people may be 
important to identify persons at risk of functional 
impairment.  
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